Potassium Hydroxide → (S)-1,2,3,4,6,11-Hexahydro-6,11-dioxopyridazino[1,2-b]phthalazine-1-carboxylic acid

HRID 1170835Notes

Reaction equation

HRID 1170835 reaction equation
C[O:2][C:3]([C@H:5]1[N:10]2[C:11](=[O:20])[C:12]3[C:17]([C:18](=[O:19])[N:9]2[CH2:8][CH2:7][CH2:6]1)=[CH:16][CH:15]=[CH:14][CH:13]=3)=[O:4].[OH-].[K+]>CO>[O:19]=[C:18]1[C:17]2[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=2)[C:11](=[O:20])[N:10]2[C@H:5]([C:3]([OH:4])=[O:2])[CH2:6][CH2:7][CH2:8][N:9]12

Participants

4

Procedure

To a stirred solution of (S)-6,11-dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxylic acid methyl ester (1.078 g, 3.93 mmol) in MeOH (35 mL) was added KOH (232 mg, 4.12 mmol) in MeOH (11 mL) at 0° C. The reaction mixture was allowed to warm to room temperature and stirred for 20 hours, then concentrated under reduced pressure. The residue was dissolved in ethyl acetate and the resulting solution was extracted with water. The aqueous phase was acidified with 2.0-M HCl then extracted several times with ethyl acetate. The combined organic extracts were dried (MgSO4), filtered and concentrated. The residue was crystallized from diethyl ether and the title compound was obtained as a white solid (744 mg, 73%): 1H NMR (400 MHz, CD3OD) δ 1.80 (1H, m), 1.97 (1H, m), 2.16 (1H, m), 2.56 (1H, m), 3.36 (1H, m), 4.83-4.88 (2H, m), 5.71 (1H, m), 7.90 (2H, m), 8.26 (2H, m).

Workup

  1. concentrationconcentrated under reduced pressure
  2. dissolutionThe residue was dissolved in ethyl acetate
  3. extractionthe resulting solution was extracted with water
  4. extractionthen extracted several times with ethyl acetate
  5. dry with materialThe combined organic extracts were dried (MgSO4)
  6. filtrationfiltered
  7. concentrationconcentrated
  8. customThe residue was crystallized from diethyl ether

Sources & evidence

ORD record
ord-5d8d94bdf8af4ffc97171718f20117e5
Source dataset
uspto-grants-2010_11
Patent number
US07829561B2

Reaction notes

Loading…